PULMATRIX, INC. Other Nonoperating Expense
PULMATRIX, INC. (PULM) reported Other Nonoperating Expense of $51.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-08-10
- PULMATRIX, INC. other nonoperating expense for the quarter ending 2022-06-30 was $51.00K, a 920.00% increase year-over-year.
- PULMATRIX, INC. other nonoperating expense for the quarter ending 2022-03-31 was $11.00K, a 50.00% decline year-over-year.
- PULMATRIX, INC. other nonoperating expense for the quarter ending 2021-06-30 was $5.00K, a 44.44% decline year-over-year.
- PULMATRIX, INC. other nonoperating expense for the quarter ending 2021-03-31 was $22.00K.
- PULMATRIX, INC. other nonoperating expense for fiscal 2021 was $11.00K, a 95.40% decline from fiscal 2020.
- PULMATRIX, INC. other nonoperating expense for fiscal 2020 was $239.00K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 12 month |
|---|---|---|---|
| 2022-06-30 | $51.00K 10-Q · filed 2022-08-10 | $62.00K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $11.00K 10-Q · filed 2022-05-12 | ||
| 2021-12-31 | $11.00K 10-K · filed 2022-03-29 | ||
| 2021-06-30 | $5.00K 10-Q · filed 2022-08-10 | $27.00K 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-12 | ||
| 2020-12-31 | $239.00K 10-K · filed 2022-03-29 | ||
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-10 | $10.00K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |